Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampus

Neuroscience

Volumn 150, Issue 4, 2007, Pages 754-763

  Hein, A M ^a   Stutzman, D L ^a   Bland, S T ^a   Barrientos, R M ^a   Watkins, L R ^a   Rudy, J W ^a   Maier, S F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

brain derived neurotrophic factor; cyclooxygenase; EP receptor; memory

Indexed keywords

INTERLEUKIN 1BETA; NAPROXEN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; ENZYME INHIBITION; FEAR; HIPPOCAMPUS; HORMONE ACTION; LEARNING DISORDER; LONG TERM MEMORY; MALE; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; SPRAGUE DAWLEY RAT; WORK CAPACITY;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; FEAR; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INTERLEUKIN-1BETA; LEARNING DISORDERS; MALE; NAPROXEN; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 36849052929     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.10.003     Document Type: Article

References (50)

1. Alonso M., Vianna M.R., Depino A.M., Mello e Souza T., Pereira P., Szapiro G., Viola H., Pitossi F., Izquierdo I., and Medina J.H. BDNF-triggered events in the rat hippocampus are required for both short- and long-term memory formation. Hippocampus 12 (2002) 551-560
2. Avitsur R., and Yirmiya R. Cytokines inhibit sexual behavior in female rats: I. Synergistic effects of tumor necrosis factor alpha and interleukin-1. Brain Behav Immun 13 1 (1999) 14-32
3. Ban E.M. Interleukin-1 receptors in the brain: characterization by quantitative in situ autoradiography. Immunomethods 5 1 (1994) 31-40
4. Barrientos R.M., Higgins E.A., Sprunger D.B., Watkins L.R., Rudy J.W., and Maier S.F. Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus. Behav Brain Res 134 (2002) 291-298
5. Barrientos R.M., Sprunger D.B., Campeau S., Higgins E.A., Watkins L.R., Rudy J.W., and Maier S.F. Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 121 4 (2003) 847-853
6. Barrientos R.M., Sprunger D.B., Campeau S., Watkins L.R., Rudy J.W., and Maier S.F. BDNF mRNA expression in rat hippocampus following contextual learning is blocked by intrahippocampal IL-1 beta administration. J Neuroimmunol 155 (2004) 119-126
7. Bishnoi M., Patil C.S., Kumar A., and Kulkarni S.K. Protective effects of nimesulide (COX inhibitor), AKBA (5-LOX inhibitor), and their combination in aging-associated abnormalities in mice. Methods Find Exp Clin Pharmacol 27 7 (2005) 465-470
8. Casadesus G., Smith M.A., Basu S., Hua J., Capobianco D.E., Siedlak S.L., Zhu X., and Perry G. Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer's disease. Mol Neurodegener 2 (2007) 2
9. Casolini P., Catalani A., Zuena A.R., and Angelucci L. Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J Neurosci Res 68 3 (2002) 337-343
10. Chen C., Magee J.C., and Bazan N.G. Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J Neurophysiol 87 6 (2002) 2851-2857
11. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 1 (1987) 156-159
12. Cunningham A.J., Murray C.A., O'Neil L.A.J., Lynch M.A., and O'Connor J.J. Interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203 (1996) 17-20
13. Dhir A., Padi S.S., Naidu P.S., and Kulkarni S.K. Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice. Eur J Pharacol 535 1-3 (2006) 192-198
14. Dinarello C.A., Gatti S., and Bartfai T. Fever: links with an ancient receptor. Curr Biol 9 4 (1999) R147-R150
15. Frank M.G., Barrientos R.M., Biedenkapp J.C., Rudy J.W., Watkins L.R., and Maier S.F. mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol Aging 27 5 (2006) 717-722
16. Gemma C., Fister M., Hudson C., and Bickford P.C. Improvement of memory for context by inhibition of caspase-1 in aged rats. Eur J Neurosci 22 7 (2005) 1751-1756
17. Gopez J.J., Yue H., Vasudevan R., Malik A.S., Fogelsanger L.N., Lewis S., Panikashvili D., Shohami E., Jansen S.A., Narayan R.K., and Strauss K.I. Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery 56 3 (2005) 590-604
18. Goshen I., and Yirmiya R. The role of pro-inflammatory cytokines in memory processes and neural plasticity. In: Ader R., Dantzer R., Glaser R., Heijnen C., Irwin M., Padgett D., and Sheridan J. (Eds). Psychoneuroimmunology. 4th ed (2006), Elsevier, New York 337-378
19. Griffin W.S.T., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., and Araoz C. Brain Interleukin-1 and S-100 Immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86 (1989) 7611-7615
20. Hall J., Thomas K.L., and Everitt B.J. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci 3 (2000) 533-535
21. Hoozemans J.J., Veerhuis R., Janssen I., Rozemuller A.J., and Eikelenboom P. Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells: implications for Alzheimer's disease. Exp Gerontol 36 3 (2001) 559-570
22. Hori T., Oka T., Hosoi M., and Aou S. Pain modulatory actions of cytokines and prostaglandin E2 in the brain. Ann N Y Acad Sci 840 (1998) 269-281
23. In't Veld B.A., Ruitenberg A., Horman A., Launer L.J., van Duijn C.M., Stijnen T., et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345 (2001) 1515-1521
24. Jain N.K., Patil C.S., Kulkarni S.K., and Singh A. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice. Behav Brain Res 133 2 (2002) 369-376
25. Kaufmann W.E., Worley P.F., Pegg J., Bremer M., and Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci U S A 93 6 (1996) 2317-2321
26. Lapchak P.A., Araujo D., and Hefti F. Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience 53 (1993) 297-301
27. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25 4 (2001) 402-408
28. Lombardi V.R., Garcia M., Rey L., and Cacabelos R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's disease (AD) individuals. J Neuroimmunol 97 (1999) 163-171
29. Maier S.F., Goehler L.E., Fleshner M., and Watkins L.R. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci 840 (1998) 289-300
30. Matsumoto Y., Yamaguchi T., Watanabe S., and Yamamoto T. Involvement of arachidonic acid cascade in working memory impairment induced by interleukin-1 beta. Neuropharmacology 46 (2004) 1195-1200
31. Mesches M.H., Gemma C., Veng L.M., Allgeier C., Young D.A., Browning M.D., and Bickford P.C. Sulindac improves memory and increases NMDA receptor subunits in aged Fischer 344 rats. Neurobiol Aging 25 3 (2004) 315-324
32. Monica E.K., Engblom D., Saha Sipra Blomqvist A., Jakobsson P.J., and Ericsson-Dahlstrand A. Inflammatory response: Pathway across the blood-brain barrier. Nature 410 (2001) 430-431
33. Montine T.J., Sidell K.R., Crews B.C., Markesbery W.R., Marnett L.J., Roberts II L.J., and Morrow J.D. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology 53 7 (1999) 1495-1498
34. Mu J.S., Li W.P., Yao Z.B., and Zhou X.F. Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain Res 835 2 (1999) 259-265
35. Narumiya S., and FitzGerald G.A. Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108 1 (2001) 25-30
36. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 (1999) 1193-1226
37. 2 in the rat Prostaglandins. Leukot Essent Fatty Acids 56 2 (1997) 165-168
38. O'Banion M.K., Miller J.C., Chang J.W., Kaplan M.D., and Coleman P.D. Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J Neurochem 66 6 (1996) 2532-2540
39. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 9 (2001) e45
40. Phillips R.G., and LeDoux J.E. Differential contribution of amygdale and hippocampus to cued and contextual fear conditioning. Behav Neurosci 106 2 (1992) 274-285
41. Pugh C.R., Kumagawa K., Fleshner M., Watkins L.R., Maier S.F., and Rudy J.W. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav Immun 12 3 (1998) 212-229
42. Pugh C.R., Nguyen K.T., Gonyea J.L., Fleshner M., Watkins L.R., Maier S.F., and Rudy J.W. Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation. Behav Brain Res 106 1-2 (1999) 109-118
43. Quan N., Stern E.L., Whiteside M.B., and Herkenham M. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol 93 (1999) 72-80
44. Rage F., Silhol M., and Tapia-Arancibia L. IL-1 beta regulation of BDNF expression in rat cultured hypothalamic neurons depends on the presence of glial cells. Neurochem Int 49 5 (2006) 433-441
45. Sato T., Ishida T., Irifune M., Tanaka K., Hirate K., Nakamura N., and Nishikawa T. Effect of NC-1900, an active fragment analog of arginine vasopressin, and inhibitors of arachidonic acid metabolism on performance of a passive avoidance task in mice. Eur J Pharmacol 560 1 (2007) 36-41
46. Shaw K.N., Commins S., and O'Mara S.M. Cyclooxygenase inhibition attenuates endotoxin-induced spatial learning deficits, but not an endotoxin-induced blockade of long-term potentiation. Brain Res 1038 2 (2005) 231-237
47. Stewart W.F., Kawas C., Corrada M., and Metter E.J. Risk of Alzheimer's disease and duration of NSAID use. Neurology 48 (1997) 626-632
48. Sugimoto Y., and Narumiya S. Prostaglandin E receptors. J Biol Chem 282 16 (2007) 11613-11617
49. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., and Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neuron: regulation by synaptic activity and glucocorticoids. Neuron 11 2 (1993) 371-386
50. Zaretsky D.V., Hunt J.L., Zaretskaia M.V., and DiMicco J.A. Microinjection of prostaglandin E2 and muscimol into the preoptic area in conscious rats: comparison of effects on plasma adrenocorticotrophic hormone (ACTH), body temperature, locomotor activity, and cardiovascular function. Neurosci Lett 397 3 (2006) 291-296